Jean-Michel Rodier

719 total citations
8 papers, 92 citations indexed

About

Jean-Michel Rodier is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Jean-Michel Rodier has authored 8 papers receiving a total of 92 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Jean-Michel Rodier's work include Cancer Treatment and Pharmacology (4 papers), Prostate Cancer Treatment and Research (3 papers) and Vitamin D Research Studies (3 papers). Jean-Michel Rodier is often cited by papers focused on Cancer Treatment and Pharmacology (4 papers), Prostate Cancer Treatment and Research (3 papers) and Vitamin D Research Studies (3 papers). Jean-Michel Rodier collaborates with scholars based in France. Jean-Michel Rodier's co-authors include Éric Raymond, Sandrine Faivre, Stéphane Oudard, Tristan Maurina, Jean-­Marc Ferrero, G. Deplanque, Pascal Houillier, Gérard Maruani, Réza Elaidi and Sarah Mackenzie and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Jean-Michel Rodier

8 papers receiving 92 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean-Michel Rodier France 4 38 37 28 25 22 8 92
Edward Y. Zhu United States 5 28 0.7× 26 0.7× 12 0.4× 16 0.6× 21 1.0× 13 73
Holly Ní Raghallaigh United Kingdom 7 24 0.6× 78 2.1× 19 0.7× 26 1.0× 11 0.5× 16 123
Katharina Leitner Austria 7 42 1.1× 12 0.3× 10 0.4× 51 2.0× 16 0.7× 20 149
Dan‐Hua Li China 8 32 0.8× 15 0.4× 21 0.8× 36 1.4× 18 0.8× 15 141
Ryszard Mężyk Poland 9 51 1.3× 11 0.3× 17 0.6× 35 1.4× 18 0.8× 20 185
Alexander Andreev-Drakhlin United States 4 32 0.8× 23 0.6× 11 0.4× 20 0.8× 6 0.3× 10 68
Prerna Guleria India 8 55 1.4× 30 0.8× 16 0.6× 14 0.6× 29 1.3× 25 149
Ofure Obazee Germany 4 26 0.7× 12 0.3× 15 0.5× 26 1.0× 23 1.0× 5 87
Dahlia Henry United States 5 65 1.7× 49 1.3× 14 0.5× 18 0.7× 9 0.4× 7 115

Countries citing papers authored by Jean-Michel Rodier

Since Specialization
Citations

This map shows the geographic impact of Jean-Michel Rodier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean-Michel Rodier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean-Michel Rodier more than expected).

Fields of papers citing papers by Jean-Michel Rodier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean-Michel Rodier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean-Michel Rodier. The network helps show where Jean-Michel Rodier may publish in the future.

Co-authorship network of co-authors of Jean-Michel Rodier

This figure shows the co-authorship network connecting the top 25 collaborators of Jean-Michel Rodier. A scholar is included among the top collaborators of Jean-Michel Rodier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean-Michel Rodier. Jean-Michel Rodier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sannier, Aurélie, Solenn Brosseau, Jean-Michel Rodier, et al.. (2019). Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma. Pathology & Oncology Research. 26(4). 2795–2800. 7 indexed citations
2.
Médioni, Jacques, G. Deplanque, Jean-­Marc Ferrero, et al.. (2014). Phase I Safety and Pharmacodynamic of Inecalcitol, a Novel VDR Agonist with Docetaxel in Metastatic Castration-Resistant Prostate Cancer Patients. Clinical Cancer Research. 20(17). 4471–4477. 32 indexed citations
3.
Azria, D., Christophe Massard, Diégo Tosi, et al.. (2012). An ambispective observational study in the safety and efficacy of abiraterone acetate in the French temporary authorizations for use (ATU): Predictive parameters of response.. Journal of Clinical Oncology. 30(5_suppl). 149–149. 19 indexed citations
4.
5.
6.
7.
8.
Rodier, Jean-Michel, et al.. (2007). Could we expect to improve survival in small cell lung cancer?. Lung Cancer. 57. S30–S34. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Edward Y. Zhu Breakdown of academic impact, for papers by Holly Ní Raghallaigh Breakdown of academic impact, for papers by Katharina Leitner Breakdown of academic impact, for papers by Dan‐Hua Li Breakdown of academic impact, for papers by Ryszard Mężyk Breakdown of academic impact, for papers by Alexander Andreev-Drakhlin Breakdown of academic impact, for papers by Prerna Guleria Breakdown of academic impact, for papers by Ofure Obazee Breakdown of academic impact, for papers by Dahlia Henry
Rankless by CCL
2026